Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Cancer preceding giant cell arteritis: a case-control study.

Kermani TA, Schäfer VS, Crowson CS, Hunder GG, Ytterberg SR, Matteson EL, Gabriel SE, Warrington KJ.

Arthritis Rheum. 2010 Jun;62(6):1763-9. doi: 10.1002/art.27429.

2.

Malignancy risk in patients with giant cell arteritis: a population-based cohort study.

Kermani TA, Schäfer VS, Crowson CS, Hunder GG, Gabriel SE, Ytterberg SR, Matteson EL, Warrington KJ.

Arthritis Care Res (Hoboken). 2010 Feb;62(2):149-54. doi: 10.1002/acr.20062.

3.

Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study.

Schäfer VS, Kermani TA, Crowson CS, Hunder GG, Gabriel SE, Ytterberg SR, Matteson EL, Warrington KJ.

Rheumatology (Oxford). 2010 Nov;49(11):2104-8. doi: 10.1093/rheumatology/keq200. Epub 2010 Jul 13.

4.

Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year Period.

Catanoso M, Macchioni P, Boiardi L, Muratore F, Restuccia G, Cavazza A, Pipitone N, Mancuso P, Luberto F, Salvarani C.

Arthritis Care Res (Hoboken). 2017 Mar;69(3):430-438. doi: 10.1002/acr.22942.

PMID:
27214746
5.

Statin use in giant cell arteritis: a retrospective study.

Schmidt J, Kermani TA, Muratore F, Crowson CS, Matteson EL, Warrington KJ.

J Rheumatol. 2013 Jun;40(6):910-5. doi: 10.3899/jrheum.121150. Epub 2013 Apr 1.

6.

Body mass index and the risk of giant cell arteritis: results from a prospective study.

Jakobsson K, Jacobsson L, Warrington K, Matteson EL, Liang K, Melander O, Turesson C.

Rheumatology (Oxford). 2015 Mar;54(3):433-40. doi: 10.1093/rheumatology/keu331. Epub 2014 Sep 5.

7.

Cardiovascular risk and acute coronary syndrome in giant cell arteritis: a population-based retrospective cohort study.

Udayakumar PD, Chandran AK, Crowson CS, Warrington KJ, Matteson EL.

Arthritis Care Res (Hoboken). 2015 Mar;67(3):396-402. doi: 10.1002/acr.22416.

8.

Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink.

Li L, Neogi T, Jick S.

Rheumatology (Oxford). 2017 May 1;56(5):753-762. doi: 10.1093/rheumatology/kew482.

PMID:
28077689
9.

Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis.

Ungprasert P, Upala S, Sanguankeo A, Warrington KJ.

Mod Rheumatol. 2016;26(3):410-4. doi: 10.3109/14397595.2015.1081722. Epub 2015 Sep 18. Review.

PMID:
26381748
10.

Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study.

Lo Gullo A, Koster MJ, Crowson CS, Makol A, Ytterberg SR, Saitta A, Salvarani C, Matteson EL, Warrington KJ.

PLoS One. 2016 Feb 22;11(2):e0149579. doi: 10.1371/journal.pone.0149579. eCollection 2016.

11.

Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based study.

Ninan J, Nguyen AM, Cole A, Rischmueller M, Dodd T, Roberts-Thomson P, Hill CL.

J Rheumatol. 2011 Oct;38(10):2215-7. doi: 10.3899/jrheum.101254. Epub 2011 Aug 15.

PMID:
21844141
12.

Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.

González-Gay MA, Garcia-Porrua C, Rivas MJ, Rodriguez-Ledo P, Llorca J.

Ann Rheum Dis. 2001 Apr;60(4):367-71.

13.

Hospitalized infections in giant cell arteritis: a population-based retrospective cohort study.

Udayakumar PD, Chandran AK, Crowson CS, Warrington KJ, Matteson EL.

J Rheumatol. 2014 Dec;41(12):2447-51. doi: 10.3899/jrheum.140124. Epub 2014 Oct 15.

14.

Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities.

Petri H, Nevitt A, Sarsour K, Napalkov P, Collinson N.

Arthritis Care Res (Hoboken). 2015 Mar;67(3):390-5. doi: 10.1002/acr.22429.

15.

Infections and the risk of incident giant cell arteritis: a population-based, case-control study.

Rhee RL, Grayson PC, Merkel PA, Tomasson G.

Ann Rheum Dis. 2017 Jun;76(6):1031-1035. doi: 10.1136/annrheumdis-2016-210152. Epub 2016 Nov 28.

PMID:
27895041
16.

Giant cell arteritis and mortality.

Crow RW, Katz BJ, Warner JE, Alder SC, Zhang K, Schulman S, Digre KB.

J Gerontol A Biol Sci Med Sci. 2009 Mar;64(3):365-9. doi: 10.1093/gerona/gln030. Epub 2009 Feb 4.

17.

Is statin exposure associated with occurrence or better outcome in giant cell arteritis? Results from a French population-based study.

Pugnet G, Sailler L, Bourrel R, Montastruc JL, Lapeyre-Mestre M.

J Rheumatol. 2015 Feb;42(2):316-22. doi: 10.3899/jrheum.140906. Epub 2014 Dec 15.

PMID:
25512477
18.

Increased risk of cardiovascular disease in giant cell arteritis: a general population-based study.

Amiri N, De Vera M, Choi HK, Sayre EC, Avina-Zubieta JA.

Rheumatology (Oxford). 2016 Jan;55(1):33-40. doi: 10.1093/rheumatology/kev262. Epub 2015 Aug 5.

PMID:
26248811
19.

Cancer in biopsy-proven giant cell arteritis. A population-based study.

Gonzalez-Gay MA, Lopez-Diaz MJ, Martinez-Lado L, Peña-Sagredo JL, Lopez-Agreda H, Miranda-Filloy JA, Gonzalez-Juanatey C, Sanchez-Andrade A, Martin J, Llorca J.

Semin Arthritis Rheum. 2007 Dec;37(3):156-63. Epub 2007 May 16.

PMID:
17509668
20.

Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany.

Reinhold-Keller E, Zeidler A, Gutfleisch J, Peter HH, Raspe HH, Gross WL.

Rheumatology (Oxford). 2000 Dec;39(12):1396-402.

PMID:
11136884

Supplemental Content

Support Center